Search Share Prices

AZN Share Price - Metastatic Bladder Cancer Market to Eyewitness Massive Growth by 2029

Research Nester released a report titled “Metastatic Bladder Cancer Market: Global Demand Analysis & Opportunity Outlook 2029” which delivers detailed overview of the global metastatic bladder cancer ...

Read More »

Non-Small Cell Lung Cancer Treatment Market Segment, Future Demand, Key Players Opportunity and Forecast, 2029

Small Cell Lung Cancer Treatment Market: Global Demand Analysis & Opportunity Outlook 2029″ which delivers detailed overview of t ...

Read More »

AstraZeneca receives green light for small cell lung cancer treatment in China

The approval was based on positive results from a phase III trial where Imfinzi showed improvement compared to chemotherapy alone ...

Read More »

FibroGen Plunges As FDA Panel Rejects Drug For Anemia Linked To Kidney Disease

FibroGen (NASDAQ: FGEN ) stock slumped 44% Friday as an advisory committee of the Food and Drug Administration rejected the company’s proposed inhibitor to treat anemia in adult patients suffering ...

Read More »

AstraZeneca and FibroGen face FDA red light over anaemia drug

Before the committee’s meeting, the FDA issued a briefing document that said the drug’s safety in CKD patients was the main issue ...

Read More »

Related Share Prices